These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728 [TBL] [Abstract][Full Text] [Related]
9. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs. Li H; Zony C; Chen P; Chen BK J Virol; 2017 May; 91(9):. PubMed ID: 28148796 [TBL] [Abstract][Full Text] [Related]
10. Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. Wu X; Guo J; Niu M; An M; Liu L; Wang H; Jin X; Zhang Q; Lam KS; Wu T; Wang H; Wang Q; Du Y; Li J; Cheng L; Tang HY; Shang H; Zhang L; Zhou P; Chen Z J Clin Invest; 2018 Jun; 128(6):2239-2251. PubMed ID: 29461979 [TBL] [Abstract][Full Text] [Related]
11. Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity. Huang Y; Yu J; Lanzi A; Yao X; Andrews CD; Tsai L; Gajjar MR; Sun M; Seaman MS; Padte NN; Ho DD Cell; 2016 Jun; 165(7):1621-1631. PubMed ID: 27315479 [TBL] [Abstract][Full Text] [Related]
12. Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes. Kong R; Louder MK; Wagh K; Bailer RT; deCamp A; Greene K; Gao H; Taft JD; Gazumyan A; Liu C; Nussenzweig MC; Korber B; Montefiori DC; Mascola JR J Virol; 2015 Mar; 89(5):2659-71. PubMed ID: 25520506 [TBL] [Abstract][Full Text] [Related]
13. Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies. Zhang Z; Li S; Gu Y; Xia N Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869733 [TBL] [Abstract][Full Text] [Related]
14. Broadly Neutralizing Antibodies: Magic Bullets against HIV? Julg B; Alter G Immunity; 2016 Jun; 44(6):1253-4. PubMed ID: 27332729 [TBL] [Abstract][Full Text] [Related]
15. Towards HIV-1 remission: potential roles for broadly neutralizing antibodies. Halper-Stromberg A; Nussenzweig MC J Clin Invest; 2016 Feb; 126(2):415-23. PubMed ID: 26752643 [TBL] [Abstract][Full Text] [Related]
16. In vivo protection by broadly neutralizing HIV antibodies. van Gils MJ; Sanders RW Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020 [TBL] [Abstract][Full Text] [Related]
17. Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment. Ferrari G J Clin Invest; 2018 Jun; 128(6):2189-2191. PubMed ID: 29683434 [TBL] [Abstract][Full Text] [Related]
18. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Georgiev IS; Doria-Rose NA; Zhou T; Kwon YD; Staupe RP; Moquin S; Chuang GY; Louder MK; Schmidt SD; Altae-Tran HR; Bailer RT; McKee K; Nason M; O'Dell S; Ofek G; Pancera M; Srivatsan S; Shapiro L; Connors M; Migueles SA; Morris L; Nishimura Y; Martin MA; Mascola JR; Kwong PD Science; 2013 May; 340(6133):751-6. PubMed ID: 23661761 [TBL] [Abstract][Full Text] [Related]